Levels of sCD40 Ligand in Chronic and Acute Coronary Syndromes and its Relation to Angiographic Extent of Coronary Arterial Narrowing

被引:11
|
作者
Fouad, Hanan H. [2 ]
Al-Dera, Husain [3 ]
Bakhoum, Sameh W. [4 ]
Rashed, Laila A. [2 ]
Sayed, Rehab H. [2 ]
Rateb, Moshira A. [5 ]
Haidara, Mohamed A. [1 ]
Soskic, Sanja [6 ]
Isenovic, Esma R. [6 ]
机构
[1] King Khalid Univ, Dept Physiol, Coll Med, Abha, Saudi Arabia
[2] Cairo Univ, Dept Med Biochem, Kasr Al Aini Fac Med, Giza, Egypt
[3] King Saud bin Abdulaziz Univ Hlth Sci, Dept Physiol, Coll Med, Riyadh, Saudi Arabia
[4] Cairo Univ, Dept Cardiol, Kasr Al Aini Fac Med, Giza, Egypt
[5] Cairo Univ, Dept Physiol, Kasr Al Aini Fac Med, Giza, Egypt
[6] Univ Belgrade, Dept Mol Genet & Radiobiol, Vinca Inst, Belgrade, Serbia
关键词
coronary artery disease; acute coronary syndrome; CD40; ligand; coronary angiogram; UNSTABLE ANGINA-PECTORIS; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; SERUM NEOPTERIN LEVELS; SMOOTH-MUSCLE-CELLS; CD40; LIGAND; ENDOTHELIAL-CELLS; TISSUE FACTOR; MATRIX METALLOPROTEINASES; CARDIOVASCULAR-DISEASE;
D O I
10.1177/0003319709356785
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We determined the serum levels of soluble CD40 ligand (sCD4OL) in patients with chronic coronary artery disease (CAD) and acute coronary syndrome (ACS). Patients with unstable angina (UA) and myocardial infarction (MI) showed significantly higher levels (P < .001) of sCD4OL compared with patients with stable angina (SA) and controls; particularly, high levels occurred in patients with UA (UA: 9.23 +/- 2.92, MI: 7.38 +/- 1.05, SA: 4.42 +/- 1.08; control: 4.01 +/- 0.87 ng/mL). There was no significant difference in sCD4OL levels between patients with UA and MI or between patients with SA and controls. Levels of sCD4OL did not show any significant correlation with peak creatine kinase (CK), CK-MB isoenzyme activity in patients with MI, troponin T serum levels in patients with UA or with culprit vessel (CV) complexity score (CVCS), type of CV lesion, or vessel score in patients with UA or MI. These results suggest that CD40L plays a pathogenic role in triggering ACS.
引用
收藏
页码:567 / 573
页数:7
相关论文
共 50 条
  • [41] The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes
    Yan, JC
    Zhu, H
    Gao, L
    Wu, ZG
    Kong, XT
    Zon, RQ
    Zhan, LZ
    CLINICA CHIMICA ACTA, 2004, 343 (1-2) : 155 - 159
  • [42] Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
    Garlichs, CD
    Eskafi, S
    Raaz, D
    Schmidt, A
    Ludwig, J
    Herrmann, M
    Klinghammer, L
    Daniel, WG
    Schmeisser, A
    HEART, 2001, 86 (06) : 649 - 655
  • [43] Quantitative angiographic measurement of absolute coronary blood flow & its relation to mortality in acute myocardial infarction
    Gibson, CM
    Mesley, R
    Saunders, T
    Hynes, C
    Murphy, S
    Zemble, R
    Marble, SJ
    McCabe, CH
    Antman, EM
    Braunwald, E
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 396A - 396A
  • [44] In acute coronary syndromes homocysteine levels are higher than in chronic stable angina and affect the risk of restenosis after primary coronary angioplasty
    Marcucci, R
    Fedi, S
    Brunelli, T
    Falai, M
    Chioccioli, M
    Giglioli, C
    Margheri, M
    Prisco, D
    Abbate, R
    Gensini, GF
    EUROPEAN HEART JOURNAL, 2000, 21 : 454 - 454
  • [45] Response to Letter Regarding Article, "Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial"
    Rosner, Gregg F.
    Kirtane, Ajay J.
    Genereux, Philippe
    Lansky, Alexandra J.
    Cristea, Ecaterina
    Weisz, Giora
    Parise, Helen
    Fahy, Martin
    Mehran, Roxana
    Stone, Gregg W.
    Gersh, Bernard J.
    CIRCULATION, 2012, 126 (18) : E295 - E295
  • [46] Significance of Soluble CD40 Ligand (sCD40L) and Matrix Metalloproteinase-9 in Risk Stratification of Acute Coronary Syndrome
    Wang, Rui
    Li, Fangjiang
    Zhang, Pengxiang
    Shi, Jinzheng
    Li, Feixing
    Li, Xiaoning
    Zhang, Aiai
    Hao, Cuijun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (07): : 1534 - 1537
  • [47] Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis
    L'Allier, PL
    Tardif, JC
    Grégoire, J
    Joyal, M
    Lespérance, J
    Fortier, A
    Guertin, MC
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (06) : 495 - 500
  • [48] Plasma Levels of Apelinergic System Components in Patients with Chronic and Acute Coronary Syndromes-A Pilot Study
    Diakowska, Dorota
    Wyderka, Rafal
    Krzystek-Korpacka, Malgorzata
    Osuch, Lukasz
    Leskow, Anna
    Soltowska, Alicja
    Stanek, Marta
    Rosinczuk, Joanna
    Jaroch, Joanna
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [49] In-hospital blood pressure variability index and its relation with cardiovascular outcomes in acute coronary syndromes
    Abdallah, Kerolos Mohsen
    Roushdy, Salwa
    Abdelrahman, Hatem
    Khairy, Ayman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0F) : F6 - F7
  • [50] Elevated levels of sCD40L during Acute Coronary Syndrom leads to systemic MIP-2 release
    Stadlbauer, T. H. W.
    Molitor, B.
    Wilhelm, J.
    Parviz, B.
    Weber, A.
    Barth, A.
    Harwaldt, P.
    Hoelschermann, H.
    Tillmanns, H.
    Hofmann, W. K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 437 - 437